Physician profile
Jack E Pulwers
NPI 1831128560
$905.36
in general payments reported to CMS, 2019-2025
16 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.81 · 2020: $21.61 · 2021: $83.56 · 2022: $87.37 · 2023: $325 · 2024: $210 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $170.60 | 2019-2024 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $144.31 | 2020-2024 | Bexsero, Trelegy Ellipta, Rotarix |
| Bayer Healthcare Pharmaceuticals INC. | $136.94 | 2023-2025 | |
| Novo Nordisk INC | $86.35 | 2024-2025 | Rybelsus, Ozempic |
| Eisai INC. | $60.69 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.41 | 2022-2025 | Xifaxan |
| Gilead Sciences, INC. | $50.48 | 2021-2022 | |
| Amgen INC. | $47.10 | 2023-2025 | Repatha, Otezla, Repatha |
| Daiichi Sankyo INC. | $46.58 | 2023-2024 | Injectafer |
| Inogen, INC. | $24.36 | 2022 | |
| Masimo Corporation | $15.82 | 2023 | Set and Rainbow Set, Patient Safetynet System |
| Edwards Lifesciences Corporation | $15.62 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Phathom Pharmaceuticals, INC. | $14.49 | 2024 | Voquezna |
| Pfizer INC. | $14.09 | 2024 | |
| Abbvie INC. | $11.81 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Pulwers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.